Article By:
Arpita Dutt
Saturday, November 5, 2016 6:49 PM EDT
Although pharma and biotech stocks are facing challenges in the form of increasing focus on the high prices of drugs, a changing competitive scenario and mixed results, the sector’s fundamentals remain strong.